Prenatal testing is changing who gets born and who doesn’t. This is just the beginning.
The COVID-19 vaccines furthest along in clinical trials are the fastest to make, but they are also the hardest to deploy.
Parents thought Donor 9623 was a genius who spoke four languages, not a college dropout with a criminal record.
The country is facing a monkey shortage.
If the FDA’s emergency authorizations aren’t used responsibly, they could lose their power.
No matter what happens now, the virus will continue to circulate around the world.
So much hope is riding on a breakthrough, but a vaccine is only the beginning of the end.
Since 2000, a strange new type of song in white-throated sparrows has spread across the continent at stunning speed.
We know very little about how reliable tests are for people who don’t feel sick.
In a Boston ICU, staff members orchestrate goodbyes over Zoom and comfort patients who would otherwise die alone.
Sheltering in place produced a “natural experiment” for urban wildlife.
Inside the U.S. and Panama’s long-running collaboration to rid an entire continent of a deadly disease.
Even as vaccines for the disease are being held up as the last hope for a return to normalcy, misinformation about them is spreading.
COVID-19 is much less severe in children, and it could have to do with a child’s still-developing immune system.
Cat owners are resorting to China’s underground marketplace to buy antivirals for a feline coronavirus.
The immunity tests were supposed to be a “game changer,” but they are instead revealing that the majority of Americans are still vulnerable to COVID-19 infection.
A near-death experience in the ICU could have lasting effects on the brain—from PTSD to cognitive impairment on par with mild dementia.
When yellow fever swept through 19th-century New Orleans, immunity became so valuable, people were willing to go to extreme lengths for protection.
If there is a way to stop COVID-19, it will be by blocking its proteins from hijacking, suppressing, and evading humans’ cellular machinery.
The lockdowns, equipment shortages, and overburdened hospitals feel all too familiar.
People who have recovered from the disease have antibodies that might help those still suffering from it.